| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Estrogen Receptor alpha | 11 | 2023 | 433 | 1.610 |
Why?
|
| Breast Neoplasms | 14 | 2025 | 2652 | 1.390 |
Why?
|
| DNA-Activated Protein Kinase | 2 | 2026 | 28 | 1.060 |
Why?
|
| Receptors, Androgen | 3 | 2026 | 419 | 1.030 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 1 | 2026 | 100 | 0.880 |
Why?
|
| Nuclear Receptor Coactivator 3 | 7 | 2020 | 257 | 0.780 |
Why?
|
| Transcription Factors | 5 | 2026 | 2452 | 0.690 |
Why?
|
| Response Elements | 3 | 2026 | 106 | 0.650 |
Why?
|
| Gene Expression Regulation, Neoplastic | 8 | 2026 | 2028 | 0.620 |
Why?
|
| Endocrine Disruptors | 3 | 2020 | 55 | 0.560 |
Why?
|
| Breast | 2 | 2018 | 217 | 0.530 |
Why?
|
| Transcription, Genetic | 8 | 2020 | 1388 | 0.530 |
Why?
|
| Drug Resistance, Neoplasm | 5 | 2024 | 816 | 0.520 |
Why?
|
| E1A-Associated p300 Protein | 4 | 2020 | 50 | 0.500 |
Why?
|
| Proteomics | 3 | 2018 | 609 | 0.480 |
Why?
|
| MCF-7 Cells | 9 | 2020 | 209 | 0.460 |
Why?
|
| RNA, Long Noncoding | 2 | 2016 | 229 | 0.450 |
Why?
|
| Estrogens | 6 | 2024 | 433 | 0.440 |
Why?
|
| Cyclin-Dependent Kinase 6 | 2 | 2025 | 49 | 0.440 |
Why?
|
| Cyclin-Dependent Kinase 4 | 2 | 2025 | 65 | 0.440 |
Why?
|
| Transcriptional Activation | 5 | 2018 | 415 | 0.410 |
Why?
|
| Cell Line, Tumor | 9 | 2026 | 3711 | 0.410 |
Why?
|
| DNA | 3 | 2020 | 1418 | 0.400 |
Why?
|
| Nucleosomes | 1 | 2013 | 35 | 0.400 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2016 | 329 | 0.400 |
Why?
|
| DNA-Binding Proteins | 4 | 2017 | 1958 | 0.380 |
Why?
|
| Neurofibromin 1 | 2 | 2025 | 58 | 0.370 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2017 | 407 | 0.360 |
Why?
|
| HeLa Cells | 8 | 2017 | 688 | 0.340 |
Why?
|
| RNA, Untranslated | 1 | 2010 | 109 | 0.300 |
Why?
|
| Antineoplastic Agents, Hormonal | 2 | 2021 | 254 | 0.280 |
Why?
|
| Receptors, Estrogen | 4 | 2025 | 732 | 0.280 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2004 | 595 | 0.270 |
Why?
|
| Neoplasm Proteins | 3 | 2024 | 677 | 0.270 |
Why?
|
| Signal Transduction | 6 | 2020 | 4675 | 0.270 |
Why?
|
| Endometriosis | 2 | 2024 | 176 | 0.260 |
Why?
|
| Promoter Regions, Genetic | 5 | 2018 | 1215 | 0.250 |
Why?
|
| Trans-Activators | 2 | 2013 | 691 | 0.250 |
Why?
|
| Nuclear Proteins | 3 | 2017 | 1219 | 0.230 |
Why?
|
| Protein Isoforms | 1 | 2026 | 419 | 0.220 |
Why?
|
| Xenograft Model Antitumor Assays | 6 | 2025 | 997 | 0.220 |
Why?
|
| Genes, ras | 1 | 2004 | 98 | 0.220 |
Why?
|
| Alternative Splicing | 1 | 2026 | 308 | 0.210 |
Why?
|
| Humans | 32 | 2026 | 130921 | 0.210 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2004 | 188 | 0.210 |
Why?
|
| Protein Binding | 5 | 2020 | 1666 | 0.200 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2025 | 619 | 0.200 |
Why?
|
| Receptors, Steroid | 1 | 2024 | 171 | 0.200 |
Why?
|
| Estrogen Antagonists | 2 | 2020 | 92 | 0.190 |
Why?
|
| Glucose | 2 | 2018 | 848 | 0.190 |
Why?
|
| Tamoxifen | 2 | 2020 | 350 | 0.180 |
Why?
|
| Animals | 17 | 2025 | 33954 | 0.170 |
Why?
|
| Unfolded Protein Response | 1 | 2020 | 62 | 0.160 |
Why?
|
| Apoptosis | 3 | 2024 | 1860 | 0.160 |
Why?
|
| Phosphorylation | 4 | 2018 | 1568 | 0.160 |
Why?
|
| Models, Biological | 3 | 2020 | 1392 | 0.160 |
Why?
|
| Organotin Compounds | 1 | 2020 | 6 | 0.160 |
Why?
|
| Stilbenes | 1 | 2020 | 36 | 0.160 |
Why?
|
| Trialkyltin Compounds | 1 | 2019 | 7 | 0.160 |
Why?
|
| Retinoid X Receptor alpha | 1 | 2019 | 16 | 0.160 |
Why?
|
| Hormones | 1 | 2020 | 164 | 0.160 |
Why?
|
| Biomarkers, Tumor | 3 | 2024 | 1622 | 0.150 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2021 | 244 | 0.150 |
Why?
|
| Chromatin Immunoprecipitation | 3 | 2016 | 231 | 0.150 |
Why?
|
| Histones | 3 | 2017 | 543 | 0.150 |
Why?
|
| Multiprotein Complexes | 3 | 2017 | 194 | 0.150 |
Why?
|
| Environmental Pollutants | 1 | 2020 | 81 | 0.150 |
Why?
|
| Cell Proliferation | 3 | 2025 | 2476 | 0.140 |
Why?
|
| Phosphofructokinase-2 | 1 | 2018 | 22 | 0.140 |
Why?
|
| Hepatocytes | 1 | 2019 | 235 | 0.140 |
Why?
|
| Guanylate Cyclase | 1 | 2017 | 33 | 0.130 |
Why?
|
| Transcription Initiation, Genetic | 1 | 2017 | 6 | 0.130 |
Why?
|
| Transcription Elongation, Genetic | 1 | 2017 | 9 | 0.130 |
Why?
|
| Down-Regulation | 1 | 2019 | 655 | 0.130 |
Why?
|
| CARD Signaling Adaptor Proteins | 1 | 2017 | 43 | 0.130 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2017 | 359 | 0.130 |
Why?
|
| Epigenesis, Genetic | 3 | 2020 | 771 | 0.130 |
Why?
|
| Histone Code | 1 | 2017 | 46 | 0.130 |
Why?
|
| RNA Polymerase II | 1 | 2017 | 88 | 0.130 |
Why?
|
| Mutation | 5 | 2023 | 6153 | 0.130 |
Why?
|
| Lysine | 1 | 2017 | 165 | 0.130 |
Why?
|
| Female | 16 | 2025 | 70722 | 0.130 |
Why?
|
| Lipid Metabolism | 1 | 2019 | 370 | 0.120 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2017 | 121 | 0.120 |
Why?
|
| Mice | 10 | 2025 | 18235 | 0.120 |
Why?
|
| Translocation, Genetic | 1 | 2018 | 351 | 0.120 |
Why?
|
| Shc Signaling Adaptor Proteins | 1 | 2015 | 10 | 0.120 |
Why?
|
| Estrogens, Conjugated (USP) | 1 | 2015 | 16 | 0.120 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2016 | 81 | 0.120 |
Why?
|
| Methyltransferases | 1 | 2016 | 77 | 0.120 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2016 | 166 | 0.110 |
Why?
|
| Luciferases | 3 | 2013 | 126 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2016 | 1226 | 0.110 |
Why?
|
| Chromatin | 1 | 2018 | 501 | 0.110 |
Why?
|
| Databases, Factual | 1 | 2019 | 1223 | 0.110 |
Why?
|
| HEK293 Cells | 4 | 2020 | 805 | 0.110 |
Why?
|
| Binding Sites | 4 | 2018 | 1147 | 0.110 |
Why?
|
| Peptide Fragments | 2 | 2017 | 686 | 0.100 |
Why?
|
| Antineoplastic Agents | 1 | 2023 | 1803 | 0.100 |
Why?
|
| Models, Molecular | 3 | 2020 | 1059 | 0.100 |
Why?
|
| Sialoglycoproteins | 1 | 2013 | 42 | 0.100 |
Why?
|
| Recombinant Proteins | 3 | 2020 | 1318 | 0.100 |
Why?
|
| Pyridines | 2 | 2025 | 258 | 0.100 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2013 | 64 | 0.100 |
Why?
|
| RNA-Induced Silencing Complex | 1 | 2013 | 11 | 0.100 |
Why?
|
| Gene Expression Regulation | 2 | 2013 | 2341 | 0.100 |
Why?
|
| Piperazines | 2 | 2025 | 271 | 0.100 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2013 | 100 | 0.100 |
Why?
|
| Blotting, Western | 3 | 2016 | 1014 | 0.090 |
Why?
|
| RNA, Small Interfering | 2 | 2016 | 658 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase 6 | 1 | 2012 | 6 | 0.090 |
Why?
|
| Ribonuclease III | 1 | 2013 | 103 | 0.090 |
Why?
|
| Cryoelectron Microscopy | 3 | 2020 | 241 | 0.090 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2013 | 162 | 0.090 |
Why?
|
| Homeostasis | 1 | 2015 | 713 | 0.090 |
Why?
|
| Protein Interaction Domains and Motifs | 3 | 2017 | 136 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-ets | 2 | 2004 | 57 | 0.090 |
Why?
|
| Forkhead Transcription Factors | 1 | 2013 | 369 | 0.080 |
Why?
|
| RNA Interference | 3 | 2018 | 492 | 0.080 |
Why?
|
| Glucose Transporter Type 3 | 1 | 2010 | 6 | 0.080 |
Why?
|
| Iodide Peroxidase | 1 | 2010 | 8 | 0.080 |
Why?
|
| Transfection | 3 | 2017 | 955 | 0.080 |
Why?
|
| Histone Acetyltransferases | 2 | 2015 | 224 | 0.080 |
Why?
|
| Molecular Dynamics Simulation | 2 | 2020 | 127 | 0.080 |
Why?
|
| Liver | 1 | 2017 | 1803 | 0.080 |
Why?
|
| Mice, Nude | 2 | 2021 | 711 | 0.070 |
Why?
|
| RNA-Binding Proteins | 1 | 2013 | 544 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 2 | 2015 | 716 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 2 | 2021 | 980 | 0.070 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2012 | 334 | 0.070 |
Why?
|
| Estradiol | 2 | 2020 | 478 | 0.070 |
Why?
|
| Cell Survival | 2 | 2020 | 845 | 0.070 |
Why?
|
| Prostatic Neoplasms | 1 | 2016 | 1416 | 0.070 |
Why?
|
| Carrier Proteins | 1 | 2013 | 1020 | 0.070 |
Why?
|
| Structure-Activity Relationship | 2 | 2020 | 554 | 0.070 |
Why?
|
| Endometrium | 2 | 2024 | 281 | 0.070 |
Why?
|
| Acetylation | 2 | 2017 | 181 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 1007 | 0.060 |
Why?
|
| Neoplasm Metastasis | 2 | 2020 | 708 | 0.060 |
Why?
|
| Lung Neoplasms | 2 | 2018 | 1547 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2013 | 900 | 0.060 |
Why?
|
| Cell Nucleus | 2 | 2020 | 564 | 0.060 |
Why?
|
| Protein Conformation | 2 | 2020 | 731 | 0.060 |
Why?
|
| Obesity | 1 | 2017 | 2388 | 0.060 |
Why?
|
| Cyclin D1 | 1 | 2025 | 109 | 0.060 |
Why?
|
| Mice, SCID | 2 | 2020 | 579 | 0.060 |
Why?
|
| Silver Staining | 1 | 2004 | 5 | 0.060 |
Why?
|
| Proto-Oncogene Protein c-ets-2 | 1 | 2004 | 8 | 0.060 |
Why?
|
| Proto-Oncogene Protein c-ets-1 | 1 | 2004 | 11 | 0.060 |
Why?
|
| Baculoviridae | 1 | 2004 | 41 | 0.060 |
Why?
|
| Chromatography, Affinity | 1 | 2004 | 53 | 0.060 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2004 | 43 | 0.060 |
Why?
|
| Acetyltransferases | 1 | 2004 | 73 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2017 | 692 | 0.050 |
Why?
|
| CREB-Binding Protein | 1 | 2004 | 55 | 0.050 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2004 | 45 | 0.050 |
Why?
|
| Genes, Reporter | 1 | 2004 | 343 | 0.050 |
Why?
|
| Male | 3 | 2026 | 64807 | 0.050 |
Why?
|
| Cell Line | 2 | 2019 | 2573 | 0.050 |
Why?
|
| Transcriptome | 2 | 2021 | 1130 | 0.050 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2024 | 224 | 0.050 |
Why?
|
| Steroids | 1 | 2024 | 170 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 1844 | 0.050 |
Why?
|
| Risk Factors | 1 | 2017 | 10997 | 0.050 |
Why?
|
| Rats | 2 | 2020 | 3434 | 0.050 |
Why?
|
| Progesterone | 1 | 2024 | 441 | 0.040 |
Why?
|
| Benzothiazoles | 1 | 2020 | 31 | 0.040 |
Why?
|
| Dihydrotestosterone | 1 | 2020 | 72 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2004 | 2401 | 0.040 |
Why?
|
| Neoplasms | 1 | 2016 | 2959 | 0.040 |
Why?
|
| X-Box Binding Protein 1 | 1 | 2020 | 28 | 0.040 |
Why?
|
| Fluorescence | 1 | 2020 | 94 | 0.040 |
Why?
|
| Receptors, Progesterone | 1 | 2024 | 675 | 0.040 |
Why?
|
| Thermodynamics | 1 | 2020 | 148 | 0.040 |
Why?
|
| Aromatase Inhibitors | 1 | 2020 | 78 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2004 | 699 | 0.040 |
Why?
|
| Prognosis | 2 | 2021 | 4953 | 0.040 |
Why?
|
| Endoribonucleases | 1 | 2020 | 86 | 0.040 |
Why?
|
| Early Growth Response Protein 1 | 1 | 2020 | 36 | 0.040 |
Why?
|
| Toxicity Tests | 1 | 2020 | 36 | 0.040 |
Why?
|
| Co-Repressor Proteins | 1 | 2020 | 38 | 0.040 |
Why?
|
| Nucleic Acid Conformation | 1 | 2020 | 180 | 0.040 |
Why?
|
| DNA, Neoplasm | 1 | 2020 | 286 | 0.040 |
Why?
|
| Deoxyglucose | 1 | 2019 | 41 | 0.040 |
Why?
|
| Knowledge Bases | 1 | 2019 | 40 | 0.040 |
Why?
|
| Amino Acid Motifs | 1 | 2020 | 194 | 0.040 |
Why?
|
| Hep G2 Cells | 1 | 2019 | 89 | 0.040 |
Why?
|
| Protein Domains | 1 | 2020 | 253 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2023 | 4665 | 0.040 |
Why?
|
| Gene-Environment Interaction | 1 | 2020 | 127 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2020 | 314 | 0.040 |
Why?
|
| Ligands | 1 | 2020 | 487 | 0.040 |
Why?
|
| ras Proteins | 1 | 2020 | 146 | 0.040 |
Why?
|
| Epigenomics | 1 | 2020 | 181 | 0.040 |
Why?
|
| Mammals | 1 | 2019 | 251 | 0.040 |
Why?
|
| Adiposity | 1 | 2020 | 207 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 4707 | 0.040 |
Why?
|
| Phosphoserine | 1 | 2018 | 38 | 0.040 |
Why?
|
| Transketolase | 1 | 2018 | 17 | 0.030 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2018 | 44 | 0.030 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2018 | 35 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2019 | 752 | 0.030 |
Why?
|
| Purines | 1 | 2018 | 115 | 0.030 |
Why?
|
| TATA Box | 1 | 1997 | 15 | 0.030 |
Why?
|
| TATA-Box Binding Protein | 1 | 1997 | 29 | 0.030 |
Why?
|
| Glycolysis | 1 | 2018 | 172 | 0.030 |
Why?
|
| Methylation | 1 | 2017 | 197 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1997 | 149 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2018 | 273 | 0.030 |
Why?
|
| Survival Rate | 1 | 2021 | 2150 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2024 | 1609 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2019 | 1619 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2017 | 409 | 0.030 |
Why?
|
| Glucokinase | 1 | 2015 | 13 | 0.030 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2015 | 51 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 1997 | 519 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 345 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 1997 | 1461 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2020 | 1092 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2016 | 1143 | 0.020 |
Why?
|
| Cell Fractionation | 1 | 2013 | 23 | 0.020 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2013 | 60 | 0.020 |
Why?
|
| Base Sequence | 1 | 1997 | 2757 | 0.020 |
Why?
|
| Environmental Exposure | 1 | 2016 | 291 | 0.020 |
Why?
|
| Drosophila | 1 | 2017 | 784 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2020 | 1838 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 1605 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 1997 | 3498 | 0.020 |
Why?
|
| Plasmids | 1 | 2013 | 453 | 0.020 |
Why?
|
| Matrix Metalloproteinases | 1 | 2012 | 61 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2013 | 783 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2012 | 360 | 0.020 |
Why?
|
| Drosophila Proteins | 1 | 2017 | 785 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 1997 | 2568 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2012 | 304 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2012 | 643 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 2020 | 1402 | 0.020 |
Why?
|
| Cell Movement | 1 | 2012 | 870 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2015 | 3840 | 0.020 |
Why?
|
| Time Factors | 1 | 2017 | 6250 | 0.020 |
Why?
|